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glyceraldehyde-3-phosphate dehydrogenase (GAPDH) results in reduced
enzyme activity, thereby reducing energy metabolites. This study aims to
determine whether PARP inhibition modulates the activity and level of poly
(ADP-ribosylation) of GAPDH, along with energy substrates within dia-
betic skeletal muscle after IR.
Methods: Two groups of db/db mice underwent 1.5 hours of unilat-
eral hind limb ischemia, followed by 24 hours reperfusion. The treatment
group (PJ) received 6 dosages of 30 mg/kg of PJ34, a PARP inhibitor, at
5 minutes before reperfusion, at 15 minutes, and at 2, 6, 12, and 18 hours
after reperfusion. The untreated group received equivalent volumes of
lactated Ringer’s (LR) vehicle at the same time points. Uninjured sham mice
were used as the control. Hind limb skeletal muscle tissue was harvested at
24 hours reperfusion to evaluate PARP and GAPDH activity, total GAPDH
expression and poly (ADP-ribosylated) GAPDH, in addition to skeletal
muscle ATP and lactate.
Results: PJ34 treatment significantly reduced PARP activity and in-
creased GAPDH activity relative to LR at 24 hours’ reperfusion (Table).
GAPDH expression was significantly lower in the PJ group. Poly (ADP-
ribosylation) of GAPDH was significantly reduced in the PJ group. PJ34
treatment significantly increased skeletal muscle ATP and lactate compared
with LR.
Conclusions: These data indicate that PARP inhibition by PJ34 in-
creased GAPDH activity, tissue lactate, and ATP, and decreased poly (ADP-
ribosylation) of GAPDH after IR. The resulting increase in tissue ATP and
lactate may provide mechanistic insight into how PARP inhibition mediates
protection against skeletal muscle IR injury.
Table.
LR PJ
P(n  6-16) (n  6-10)
PARP activity (% control) 300  48 221  20 .0043
GAPDH activity (U/2-
mg protein) 0.31  0.04 0.5  0.04 .0005
GAPDH expression (%
control) 122.5  8 94  6 .0008
GAPDH poly (ADP-
ribosylation) (AU) 1.5  0.23 0.41  0.13 .0002
Muscle ATP (nmol/g
tissue) 0.3  0.1 0.84  0.3 .0046
Muscle lactate (g/g
tissue) 229  10 375.6  48 .00004
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Introduction and objectives: Dietary restriction (DR; reduced food
intake without malnutrition) effectively reduces the acute response to sur-
gical stress in preclinical models likely by anti-inflammatory and antioxidant
mechanisms. Leveraging a novel murine carotid focal stenosis model, we
tested the hypothesis that DR would attenuate the arterial intimal hyperpla-
sia (IH) response.
Methods: A focal stenosis in 8-week-old C57BL/6J mice was created
by placing a 9-0 nylon suture tie around the distal common carotid artery
and an external 35-gauge needle mandrel (outer diameter, .014 mm) and
then removing the mandrel (78% lumen diameter reduction, 90% flow
reduction). Animals received 60 kcal% fat diet-induced obesity (DIO) chow
at baseline, and then the same chow (n  10) or 10 kcal% fat normal chow
(NC; n  10) postoperatively. One group (n  20) had a water-only fast
(DR) 72 hours before focal stenosis creation, then NC. Tissues were
perfusion-fixed 4 weeks later. Immunohistochemical staining was performed
for CD31, F4/80, and -actin.
Results: Switching to NC postoperatively reduced IH (P  .001) and
adventitial macrophages (P  .05; Fig). Brief preoperative DR even further
attenuated IH (P  .001) and yielded increased IH neovessel formation
(P  .05).
Conclusions: This murine focal carotid stenosis model offers a
straightforward method to dissect the mechanisms of arterial IH. Postoper-
ative NC rather than DIO attenuates IH. Short-term preoperative DR
further downregulates the longer-term arterial IH response, and this is
associated with less macrophage infiltration and increased IH neovascularity.
These dietary manipulations potentially offer a practical approach to extend
the durability of acute vascular interventions.
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Introduction and objectives: Intimal hyperplasia (IH) remains the
leading cause for prosthetic arterial graft failure. A composite of electrospun
polymers, such as nondegradable polymer, polyethylene terephthalate
(ePET) with a degradable polymer, and polyglycolic acid (PGA) infused
with biologically active material that can prevent the development of IH is an
appealing alternative to other clinically used grafts made of polytetrafluoro-
ethylene (PTFE).
Methods: Electrospun grafts were synthesized from ePET, copolymer
of ePET/ePGA (90:10, PET/PGA mixture resulting in a single fiber), or
cospun ePET/ePGA (90:10, individual PET and PGA fibers interspersed).
Pieces of grafts (5 mm2) were incubated in saline at 37°C for 7, 14, and 21
days and imaged using scanning electron microscopy. Attachment and
viability of human aortic smooth muscle cells (HAoSMC) seeded onto the
materials were analyzed 3 and 48 hours later, and comparisons were made
with HAoSMCs seeded on PTFE. In addition, siGLO Red (control short
interfering [si]RNA with DyLight-547 fluorescent tag) was infused into
PGA fibers of the cospun graft and siRNA degradation was observed using
confocal microscopy.
Results: Scanning electron microscopy images indicated breakage of
ePET/ePGA copolymer fibers at days 14 and 21, whereas the cospun
ePET/ePGA material showed intact ePET fibers and fragmented ePGA
fibers. Compared with PTFE, HAoSMC demonstrated a greater affinity and
viability towards electrospun materials and significantly more to cospun
ePET/ePGA. Integration of siGLO Red into PGA fibers of cospun grafts
was successful, and red fluorescent density decreased 90% in 2 weeks,
indicating release of siGLO Red.
Conclusions: Cospun ePET/ePGA remained intact after PGA degra-
dation, whereas the copolymer showed fiber breaks and fragility, making
cospun material more favorable as prosthetic arterial bypass grafts. Electro-
spun composite grafts did not impair HAoSMC attachment and growth.
siGLO Red was successfully incorporated and released from cospun ePET/
ePGA. Electrospun composite grafts can act as a delivery platform for gene
silencing to control IH.
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Introduction and objectives: Bone marrow aspirate concentrate
(BMAC), which contains cells with regenerative properties, has been studied
as a treatment for critical limb ischemia (CLI). We report the intermediate-
term results of a BMAC pilot study.
Methods: A prospective, randomized, placebo-controlled trial of
BMAC in CLI was conducted in Rutherford 4 (rest pain) and Rutherford 5
(limited tissue loss) patients. All patients were poor candidates for conven-
tional revascularization due to anatomic or physiologic considerations.
Patients were treated in a single session with aspiration of bone marrow and
preparation of BMAC injectate or placebo (peripheral blood). Forty injec-
tions were made percutaneously into the ischemic extremity and distributed
in a linear fashion along the ischemic gradient. An initial analysis previously
reported 3-month data and we are now reporting the 12-month (interme-
diate) follow-up.
Results:Of 48 patients who were treated (mean age, 69.5 years; range,
42-93), 18 (37.5%) were Rutherford 4 and 30 (62.5%) were Rutherford 5.
Fig.
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